Response to osimertinib in a colorectal cancer patient with an EGFR T790M mutation: A case report

BACKGROUND: Although common in lung cancer, somatic epidermal growth factor receptor (EGFR) mutations are rarely found in colorectal cancer, occurring in approximately 3% of cases. Treatment with anti-EGFR antibodies is commonplace, but EGFR tyrosine kinase inhibitors are not standard treatments in...

Descripción completa

Detalles Bibliográficos
Autores principales: Buzard, Blake, Douglass, Lindsey, Gustafson, Beth, Buckley, Jennifer, Roth, Marc, Kujtan, Lara, Bansal, Dhruv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631437/
https://www.ncbi.nlm.nih.gov/pubmed/37969405
http://dx.doi.org/10.4251/wjgo.v15.i10.1829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631437/
https://www.ncbi.nlm.nih.gov/pubmed/37969405
http://dx.doi.org/10.4251/wjgo.v15.i10.1829

Ejemplares similares